Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Manley

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Nephrology|May 1, 2019
Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantationBasil Alnasrallah, Tze Liang Goh, Lai Wan Chan, et al.
Neuro-Oncology|July 6, 2011
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2Sylwia Ammoun, Marei Caroline Schmid, Joceline Triner, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searchingPascal Furet, Guido Bold, Francesco Hofmann, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 23, 2024
Changing mindsets about methotrexate in the rheumatology clinic to reduce side effects and improve adherence: a randomized controlled trialRachael Yielder, Kari Leibowitz, Alia J Crum, et al.
Biomedicines|May 28, 2022
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal TumorPatrick Schöffski, Yemarshet Gebreyohannes, Thomas Van Looy, et al.
Nephrology (Carlton, Vic.)|October 4, 2006
Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 casesIan J Simpson, Mark R Marshall, Helen Pilmore, et al.
Histology and Histopathology|March 28, 2008
Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosisAled Lewis, Robert Steadman, Paul Manley, et al.
Cancer Cell|July 19, 2002
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Ellen Weisberg, Christina Boulton, Louise M Kelly, et al.
Personalized Medicine|May 18, 2018
Personalized hypertension management in practicePatrick A Gladding, Alasdair Patrick, Paul Manley, et al.
Leukemia Research|May 10, 2006
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cellsSrdan Verstovsek, Francis J Giles, Alfonso Quintás-Cardama, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Nephrology|May 1, 2019
Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantationBasil Alnasrallah, Tze Liang Goh, Lai Wan Chan, et al.
Neuro-Oncology|July 6, 2011
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2Sylwia Ammoun, Marei Caroline Schmid, Joceline Triner, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searchingPascal Furet, Guido Bold, Francesco Hofmann, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 23, 2024
Changing mindsets about methotrexate in the rheumatology clinic to reduce side effects and improve adherence: a randomized controlled trialRachael Yielder, Kari Leibowitz, Alia J Crum, et al.
Biomedicines|May 28, 2022
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal TumorPatrick Schöffski, Yemarshet Gebreyohannes, Thomas Van Looy, et al.
Nephrology (Carlton, Vic.)|October 4, 2006
Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 casesIan J Simpson, Mark R Marshall, Helen Pilmore, et al.
Histology and Histopathology|March 28, 2008
Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosisAled Lewis, Robert Steadman, Paul Manley, et al.
Cancer Cell|July 19, 2002
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412Ellen Weisberg, Christina Boulton, Louise M Kelly, et al.
Personalized Medicine|May 18, 2018
Personalized hypertension management in practicePatrick A Gladding, Alasdair Patrick, Paul Manley, et al.
Leukemia Research|May 10, 2006
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cellsSrdan Verstovsek, Francis J Giles, Alfonso Quintás-Cardama, et al.
Pageof 4